(Q45071770)

9 December 2017

1 reference

title

Inflammation, inflammatory mediators, and mediator antagonists in asthma (English)

1 reference

9 December 2017

1 reference

Lazarus SC

1

1 reference

9 December 2017

language of work or name

1 reference

1 July 1998

1 reference

The Journal of Clinical Pharmacology

9 December 2017

published in

1 reference

9 December 2017

volume

38

1 reference

9 December 2017

issue

7

1 reference

9 December 2017

page(s)

577-582

1 reference

An economic evaluation of asthma in the United States

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04463.X

Asthma and allergic rhinitis in Swedish conscripts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04463.X

Has the prevalence of asthma increased in children? Evidence from the national study of health and growth 1973-86

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04463.X

21 January 2018

Is asthma increasing?

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04463.X

Evidence for elevated levels of histamine, prostaglandin D2, and other bronchoconstricting prostaglandins in the airways of subjects with mild asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04463.X

Airway mucosal inflammation even in patients with newly diagnosed asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04463.X

Histochemical Characteristics and Degranulation of Mast Cells in Epithelium and Lamina Propria of Bronchial Biopsies from Asthmatic and Normal Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04463.X

21 January 2018

Asthma and inflammation

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04463.X

New aspects of the therapeutic potential of theophylline in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04463.X

Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04463.X

Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04463.X

Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04463.X

Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04463.X

What role for inhaled steroids in chronic asthma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04463.X

Effect of high dose inhaled fluticasone propionate on airway inflammation in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04463.X

Inhaled corticosteroids reduce the severity of bronchial hyperresponsiveness in asthma but oral theophylline does not.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04463.X

Issues in the use of inhaled glucocorticoids. The Asthma Clinical Research Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04463.X

THE LIBERATION OF A SLOW-REACTING SMOOTH MUSCLE-STIMULATING SUBSTANCE IN ANAPHYLAXIS

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04463.X

Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04463.X

Inhalation challenge with sulfidopeptide leukotrienes in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04463.X

Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04463.X

Preclinical exploration of the potential antiinflammatory properties of the peptide leukotriene antagonist ICI 204,219 (Accolate).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04463.X

Slow-reacting substances (leukotrienes) contract human airway and pulmonary vascular smooth muscle in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04463.X

Allergen-Induced Release of Sulphidopeptide Leukotrienes (SRS-A) and LTB4in Allergic Rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04463.X

Elevated levels of leukotriene C4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04463.X

Allergen-stimulated release of thromboxane A2 and leukotriene E4 in humans. Effect of indomethacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04463.X

Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04463.X

The leukotriene receptor antagonist zafirlukast inhibits sulfur dioxide-induced bronchoconstriction in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04463.X

Role of leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04463.X

The Pivotal Role of 5-Lipoxygenase Products in the Reaction of Aspirin-sensitive Asthmatics to Aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04463.X

Effect of the leukotriene receptor antagonist MK-0679 on baseline pulmonary function in aspirin sensitive asthmatic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04463.X

Lung function improvement in asthma with a cysteinylleukotriene receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04463.X

Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04463.X

A specific LTD4/LTE4-receptor antagonist improves pulmonary function in patients with mild, chronic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04463.X

Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial. Zileuton Clinical Trial Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04463.X

Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04463.X

Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04463.X

Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04463.X

Leukotrienes are potent constrictors of human bronchi

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04463.X

10.1002/J.1552-4604.1998.TB04463.X

21 January 2018

Identifiers

DOI

1 reference

9 December 2017

1 reference